A Netherlands-based biotechnology company has announced progress on its phase II/III mesothelioma study, looking at the impact of its dendritic cell therapy on patients diagnosed with the rare and deadly asbestos-caused cancer. Amphera B.V.’s entire focus is on dendritic cell therapy, and is currently planning three different clinical trials: this is its first, which will…
The post New Study to Test Dendritic Cell Immunotherapy Treatment on Mesothelioma appeared first on Mesothelioma.net.
from Mesothelioma.net https://ift.tt/2FyQpfx
via IFTTT
New Study to Test Dendritic Cell Immunotherapy Treatment on Mesothelioma
![New Study to Test Dendritic Cell Immunotherapy Treatment on Mesothelioma]()
Reviewed by Unknown
on
March 25, 2019
Rating:
No comments: